CPI began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom.

Lincoln Property Company is creating a mixed-use campus in Lexington, Mass.

Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds.

Facility Logix, EwingCole, and Biggins Lacy Shapiro have launched Rapid Reshore & Development (RR&D) to provide turnkey p

Construction began in October of 2020 on the $44.2 million Discovery Square 2 building in Rochester, Minn.

King Street Properties has fully leased a 214,440-sf research facility in Lexington, Mass., to four pharmaceutical companies.

Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas.

Codiak BioSciences is constructing a 12,000-sf clinical manufacturing center in Lexington, Mass.

CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district.

Lincoln Property Company broke ground in July of 2020 on a 140,000-sf life science building in Waltham, Mass.